NCT05072262View on ClinicalTrials.gov

DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

October 31, 2026

Conditions
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)Descemet Membrane Endothelial Keratoplasty (DMEK)
Interventions
DRUG

Nepafenac Ophthalmic

Topical nepafenac (Nevanac) 3 mg/ml

DRUG

Dexamethasone Ophthalmic

Topical dexamethasone 1 mg/ml (Spersadex)

Trial Locations (1)

Unknown

RECRUITING

Department of Ophthalmology, Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER